Ingenuity BioSolutions LLC is a scientific consulting company that enables confident, data-driven decisions in the pharmaceutical and biotech industry
Medical Writing • Drug Developement • Translational Research Preclinical Development • Clinical Development • Biomarker Strategies • Project Management
About
Navi Mehra, PhD
Navi Mehra is a visionary, dynamic and effective scientific professional with over 15 years combined experience in the pharmaceutical and CRO industries. She has extensive, proven experience utilizing a science-centric approach in establishing and leading teams in drug development for preclinical and clinical development. Dr. Mehra is founder of Ingenuity BioSolutions LLC, a consulting firm that applies deep industry knowledge and substantive technical expertise to provide strategic clinical solutions. Prior to founding Ingenuity BioSolutions, Dr. Mehra has held several successful senior scientist positions where she led multidisciplinary teams in creating preclinical and clinical solutions for pharmaceutical clients. Dr. Mehra has also successfully designed, developed, and led bioanalytical studies to explore the efficacy of the lead compound in various indications, contributing to IND filing.
Dr. Mehra obtained her Ph.D. in Genetics from University of California at Davis and completed a postdoctorate at Stanford University. She has authored numerous peer reviewed journal publications and poster presentations presented at national conferences. Her greatest values are hard-work, dedication, and respect for others.
Services
Expertise. Intuition. Ingenuity.
Medical Writing
Providing concise, quality documents
Medical writing is Ingenuity BioSolutions' core aspect. Ingenuity provides clear, quality documents that are sound from a scientific and regulatory aspect. Documents include clinical study protocols and amendments, project execution plans, clinical reports, marketing material, journal manuscripts, poster abstracts, and other study-related documents. Documents are prepared using either regulatory agency guidelines or client-provided templates.
Drug Discovery
Optimizing the value of your drug program
Ingenuity BioSolutions consults in all aspects of early drug discovery including lead identification, hit-to-lead chemistry, lead optimization, and clinical candidate selection. Our guidance will lead to selection of the most optimal model, endpoints, and time points, We pride ourselves on giving sound, truthful advice to help advance your drug discovery program.
Preclinical Development
Preparing innovative designs for drug testing
Transition from lead candidate to proof of concept with a solid strategy and plan guided by Ingenuity BioSolutions. We facilitate client-initiated research and oversee research milestone requirements to assure progression of protocols and PEPs. Ingenuity specializes in GLP/GCP compliance, animal study design, biomarker strategies, research controls, and data interpretation. Additionally, oversight is provided in the identification, evaluation, and selection of appropriate CROs and other outside vendors.
Clinical Strategies
Implementing your strategic vision
Ingenuity BioSolutions understands and develops your strategic vision. These strategies include validation design, patient enrollment strategies, feasibility and risk assessments, and incorporation of biomarkers. We provide assistance in the planning, execution, and completion of clinical trials according to all applicable regulations and guidance and client SOPs. This includes providing consultation on study design, objectives, endpoints, and statistical analysis.
Contact
